ICON plc ICLR
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
ICON plc is a leading global contract research organization (CRO) that provides outsourced drug and device development and commercialization services to pharmaceutical, biotechnology, medical device, and government organizations. It specializes in full-service clinical trials from Phase I to IV, including complex multi…
SectorHealthcare
ExchangeNASDAQ
IndustryDiagnostics & Research
CountryIreland
Employees40,100
TickerICLR
Statistics
Market Cap$10.96B
Revenue (TTM)$8.25B
Net Income$229.3M
Net Margin2.8%
EPS$2.91
P/E51.52
P/S1.39
P/B1.25
EV/EBITDA10.02
ROE2.5%
Dividend Yield—
Price$143.12
Data: Twelve Data · Revenue = mcap / P/S